12.000
−1,64%
2026-10-19
Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +127.3% | +48.7% | 2 / 3 | +137.7% | -3.12 pp | -0.18 pp | +7.2% | 0.05 | 15.41 | 180 | +137,7% | 7,1 | +127,3% | 15.41 | 22.21 | −30,6% |
| Pts | 12 | 12 | 8 | 12 | 0 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 12.000 (close price on 2026-10-19)EPS (TTM): 778,9
Financial charts
1.Revenue & growth
VND bn161Q2/26
1.Revenue & growth
VND bn161Q2/26
2.Profit & growth
VND bn6,17Q2/26
3.Profit mix (Penman)
VND bn36,5Q2/26
4.Margins & cost structure
%9.8%Q2/26
5.Returns & cash cycle
% · days7.3%Q2/26
6.Earnings quality & cash
VND bn23,8Q2/26
7.Asset structure
VND bn726Q2/26
8.Funding & debt health
VND bn · times726Q2/26
9.Revenue backlog
VND bn64,3Q2/26
10.Valuation
times · %17,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %153Q2/26
Adjusted EPS growth, latest quarter
-27.8%
Average adjusted EPS growth, 3 quarters
24.2%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26